Pathological Complete Response in Patients With Resected Pancreatic Adenocarcinoma After Preoperative ChemotherapyThomas F. Stoop, Toru Nakamura, Alain Sauvanet et al.|JAMA Network Open|2024Cited by 31
Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOXThomas F. Stoop, William R. Burns, Toshitaka Sugawara et al.|JAMA Oncology|2025Cited by 16
The impact of neoadjuvant therapy in patients with left-sided resectable pancreatic cancer: an international multicenter studyElena Rangelova, Emanuele F. Kauffmann, Thomas F. Stoop et al.|Annals of Oncology|2025Cited by 11
Survival after neoadjuvant and induction FOLFIRINOX versus gemcitabine-nab-paclitaxel in patients with resected localised pancreatic adenocarcinoma: an international multicentre studyThomas F. Stoop, Jin He, Yan‐Dong Wu et al.|British Journal of Cancer|2025Cited by 8
Minimally Invasive Versus Open Left Pancreatectomy for Resectable Pancreatic Cancer: Long-Term Results of the Randomized DIPLOMA TrialC.L. Bruna, Merna Hazem Saad Emam Mohamed Hilal, Jony van Hilst et al.|SSRN Electronic Journal|2025Cited by 0